Page last updated: 2024-08-21

aluminum oxide and Albuminuria

aluminum oxide has been researched along with Albuminuria in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bjursell, M; Erlandsson, F; Greene, TA; Heerspink, HJL; Inker, LA; Perkovic, V; Perl, S; Rikte, T; Stack, AG; Terkeltaub, R	1

Trials

1 trial(s) available for aluminum oxide and Albuminuria

Article	Year
Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2022, 07-26, Volume: 37, Issue:8 Topics: Adult; Albuminuria; Allopurinol; Aluminum Oxide; Clinical Trials, Phase II as Topic; Demography; Diabetes Mellitus, Type 2; Glomerular Filtration Rate; Humans; Hyperuricemia; Naphthalenes; Propionates; Pyridines; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic	2022

Article

Year

Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2022, 07-26, Volume: 37, Issue:8

Topics: Adult; Albuminuria; Allopurinol; Aluminum Oxide; Clinical Trials, Phase II as Topic; Demography; Diabetes Mellitus, Type 2; Glomerular Filtration Rate; Humans; Hyperuricemia; Naphthalenes; Propionates; Pyridines; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic

2022